Cambridge, MA, United States of America

Fulcrum Therapeutics, Inc.


Patents = 8

Trademarks = 14

Forward Citations = 13


where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents


20 inventors (with patents filed for the assignee):

goldMedal Owen Brendan Wallace (7 out of 7 patents)

silverMedal Lorin A Thompson, Iii (7 out of 7 patents)

bronzeMedal Luis Gustavo Alejandro Rojas Soto (4 out of 4 patents)

4 Lucienne V Ronco (4 out of 4 patents)

5 Ning Shen (4 out of 4 patents)

6 Alan Scott Robertson (4 out of 4 patents)

7 Aaron Nakwon Chang (4 out of 4 patents)

8 Angela Marie Cacace (4 out of 12 patents)

9 Qingyi Li (3 out of 8 patents)

10 Peter B Rahl (3 out of 9 patents)

11 Ivan Viktorovich Efremov (3 out of 25 patents)

12 Steven Kazmirski (3 out of 3 patents)

13 Shawn Donald Johnstone (3 out of 3 patents)

14 Feng Zhou (3 out of 3 patents)

15 Michael R Green (1 out of 28 patents)


8 patents:

1. 12109198 - Macrocyclic azolopyridine derivatives as EED and PRC2 modulators (2024-10-08),
Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on unlocking gene control mechanisms to develop small molecule therapies for serious genetic diseases. The company's proprietary product engine integrates insights from chromatin biology and transcriptional regulation to identify and drug master control nodes within disease-associated genes.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

...
8 Patents

#243 in Cambridge, MA

#2,031 in Massachusetts

#34,838 in US

...
Cambridge, MA, United States of America
Forward Citations = 13

20 inventors:

Please report any incorrect information to support@idiyas.com
Loading…